Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Cost considerations regarding the prospective surveillance model for breast cancer survivors.

Cheville AL, Nyman JA, Pruthi S, Basford JR.

Cancer. 2012 Apr 15;118(8 Suppl):2325-30. doi: 10.1002/cncr.27473. Review.

2.

Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care.

Gerber LH, Stout NL, Schmitz KH, Stricker CT.

Cancer. 2012 Apr 15;118(8 Suppl):2201-6. doi: 10.1002/cncr.27472. Review.

3.

Stakeholder perspectives on dissemination and implementation of a prospective surveillance model of rehabilitation for breast cancer treatment.

Stout NL, Andrews K, Binkley JM, Schmitz KH, Smith RA.

Cancer. 2012 Apr 15;118(8 Suppl):2331-4. doi: 10.1002/cncr.27470. Review.

4.

Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer.

Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V, Rowden D.

Cancer. 2012 Apr 15;118(8 Suppl):2207-16. doi: 10.1002/cncr.27469. Review.

5.

A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues.

McNeely ML, Binkley JM, Pusic AL, Campbell KL, Gabram S, Soballe PW.

Cancer. 2012 Apr 15;118(8 Suppl):2226-36. doi: 10.1002/cncr.27468. Review.

6.

A prospective surveillance model for rehabilitation for women with breast cancer.

Stout NL, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, McNeely ML, Soballe PW, Berger AM, Cheville AL, Fabian C, Gerber LH, Harris SR, Johansson K, Pusic AL, Prosnitz RG, Smith RA.

Cancer. 2012 Apr 15;118(8 Suppl):2191-200. doi: 10.1002/cncr.27476. Review.

7.

Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.

Hayes SC, Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, Schmitz KH.

Cancer. 2012 Apr 15;118(8 Suppl):2237-49. doi: 10.1002/cncr.27467. Review.

8.

Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals.

Harris SR, Schmitz KH, Campbell KL, McNeely ML.

Cancer. 2012 Apr 15;118(8 Suppl):2312-24. doi: 10.1002/cncr.27461. Review.

9.

A prospective model of care for breast cancer rehabilitation: function.

Campbell KL, Pusic AL, Zucker DS, McNeely ML, Binkley JM, Cheville AL, Harwood KJ.

Cancer. 2012 Apr 15;118(8 Suppl):2300-11. doi: 10.1002/cncr.27464. Review.

10.

A prospective model of care for breast cancer rehabilitation: bone health and arthralgias.

Winters-Stone KM, Schwartz AL, Hayes SC, Fabian CJ, Campbell KL.

Cancer. 2012 Apr 15;118(8 Suppl):2288-99. doi: 10.1002/cncr.27465. Review.

11.

Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.

Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR.

Cancer. 2012 Apr 15;118(8 Suppl):2270-6. doi: 10.1002/cncr.27462. Review.

12.

A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.

Stubblefield MD, McNeely ML, Alfano CM, Mayer DK.

Cancer. 2012 Apr 15;118(8 Suppl):2250-60. doi: 10.1002/cncr.27463. Review.

13.

Cancer-related fatigue: implications for breast cancer survivors.

Berger AM, Gerber LH, Mayer DK.

Cancer. 2012 Apr 15;118(8 Suppl):2261-9. doi: 10.1002/cncr.27475. Review.

14.

Survivorship: adult cancer survivors.

Ganz PA.

Prim Care. 2009 Dec;36(4):721-41. doi: 10.1016/j.pop.2009.08.001. Review.

PMID:
19913184
15.
16.
17.

Cancer prehabilitation and its role in improving health outcomes and reducing health care costs.

Silver JK.

Semin Oncol Nurs. 2015 Feb;31(1):13-30. doi: 10.1016/j.soncn.2014.11.003. Epub 2014 Dec 3. Review.

PMID:
25636392
18.

The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature.

Bestvina CM, Zullig LL, Yousuf Zafar S.

Future Oncol. 2014 Nov;10(14):2189-99. doi: 10.2217/fon.14.130. Review. Erratum in: Future Oncol. 2015;11(3):544.

PMID:
25471033

Supplemental Content

Support Center